Detalles de la búsqueda
1.
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.
Cell
; 158(4): 929-944, 2014 Aug 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-25109877
2.
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
Proc Natl Acad Sci U S A
; 120(52): e2313693120, 2023 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117852
3.
B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast cancer.
Breast Cancer Res
; 25(1): 117, 2023 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37794508
4.
Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance.
Mol Cancer
; 22(1): 15, 2023 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36681803
5.
Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial.
Breast Cancer Res Treat
; 199(2): 281-291, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37029329
6.
Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study.
Breast Cancer Res Treat
; 198(2): 383-390, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689092
7.
Somatic mutations reveal asymmetric cellular dynamics in the early human embryo.
Nature
; 543(7647): 714-718, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28329761
8.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902335
9.
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
Int J Cancer
; 150(12): 2072-2082, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35179782
10.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721561
11.
Incorporation of Patient-Reported Outcomes Measurement Information System to assess quality of life among patients with breast cancer initiating care at an academic center.
Cancer
; 127(13): 2342-2349, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33957704
12.
Prediction and clinical utility of a contralateral breast cancer risk model.
Breast Cancer Res
; 21(1): 144, 2019 12 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31847907
13.
Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
Ann Surg
; 270(2): 364-372, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29727326
14.
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.
N Engl J Med
; 375(8): 717-29, 2016 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557300
15.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27406346
16.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27406347
17.
Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women.
J Genet Couns
; 28(3): 507-515, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663827
18.
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.
Genome Res
; 25(6): 814-24, 2015 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963125
19.
The landscape of cancer genes and mutational processes in breast cancer.
Nature
; 486(7403): 400-4, 2012 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22722201
20.
The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.
Breast Cancer Res
; 19(1): 99, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851423